Clinical Trial Update: Study of Decitabine Induction Prior to Allogeneic Hematopoietic Cell Transplant in Newly Diagnosed MDS Patients [Phase 2]

View source ↗

Summary

Phase 2 study of decitabine induction before allogeneic hematopoietic cell transplant in newly diagnosed myelodysplastic syndrome patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Singapore General Hospital | Conditions: Myelodysplastic Syndrome | Phase 2 | Status: TERMINATED